☆ 4.5 Letter

Attitudes towards vaccination against group B streptococcus in pregnancy

ARCHIVES OF DISEASE IN CHILDHOOD (2014)

期刊

ARCHIVES OF DISEASE IN CHILDHOOD

卷 99, 期 7, 页码 700-U104

出版社

BMJ PUBLISHING GROUP

DOI: 10.1136/archdischild-2013-305716

关键词

-

类别

Pediatrics

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Immunology

Maternal vaccination against group B Streptococcus glyceraldehyde-3-phosphate dehydrogenase leads to gut dysbiosis in the offspring

Elva Bonifacio Andrade, Ines Lorga, Susana Roque, Rafaela Geraldo, Pedro Mesquita, Rogerio Castro, Luisa Simoes-Costa, Madalena Costa, Augusto Faustino, Adilia Ribeiro, Margarida Correia-Neves, Patrick Trieu-Cuot, Paula Ferreira

Summary: This study found that using GBS GAPDH as a maternal vaccine candidate may result in abnormal development of the offspring's intestinal and immune systems, as well as behavioral abnormalities later in life.

BRAIN BEHAVIOR AND IMMUNITY (2022)

添加到收藏夹

Article Immunology

Health-Economic Value of Vaccination Against Group A Streptococcus in the United States

Kristin Andrejko, Lilith K. Whittles, Joseph A. Lewnard

Summary: Group A Streptococcus (GAS) causes significant economic burden in the United States, with potential cost savings achievable through prevention of invasive disease and acute upper respiratory infections. Vaccines meeting WHO-PPP characteristics at specific ages could avert millions of dollars annually, with indirect effects of vaccination programs further reducing costs across all age groups. This study emphasizes the importance of prioritizing GAS vaccine development and evaluation.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Obstetrics & Gynecology

Women's knowledge of and attitudes towards group B streptococcus (GBS) testing in pregnancy: a qualitative study

Georgina Constantinou, Susan Ayers, Eleanor J. Mitchell, Kate F. Walker, Jane Daniels, Sarah Moore, Anne-Marie Jones, Soo Downe

Summary: 20-25% of pregnant women in the UK carry group B streptococcus (GBS), which can be transmitted to babies during birth and cause significant mortality and morbidity in newborns. Women's knowledge of GBS is low and attitudes towards GBS testing have not been widely examined. This study aims to explore women's knowledge of GBS and their attitudes towards GBS testing.

BMC PREGNANCY AND CHILDBIRTH (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Early-onset group B streptococcal disease in African countries and maternal vaccination strategies

Ziyaad Dangor, Anna C. Seale, Vuyelwa Baba, Gaurav Kwatra

Summary: Invasive group B streptococcal (GBS) disease is a significant problem in newborns, especially in African countries where preventive strategies are limited. The high mortality and serious neurodevelopmental impairments caused by GBS emphasize the need for a maternal vaccine. Ongoing clinical trials are evaluating the safety and efficacy of hexavalent polysaccharide protein conjugate and Alpha family surface protein vaccines.

FRONTIERS IN PUBLIC HEALTH (2023)

添加到收藏夹

Article Immunology

Stakeholder Perceptions About Group B Streptococcus Disease and Potential for Maternal Vaccination in Low- and Middle-Income Countries

Carsten Mantel, Thomas Cherian, Melissa Ko, Stefano Malvolti, Elizabeth Mason, Michelle Giles, Philipp Lambach

Summary: This study conducted a rapid literature appraisal and a multicountry survey to gather information on stakeholders' perceptions of the public health importance of GBS disease and vaccination. The findings will inform evidence-based decision making on GBS vaccination.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Infectious Diseases

Parental Attitudes Towards Vaccination Against COVID-19 in China During Pandemic

Lingling Lu, Wei Gu, Hang Xie, Xu Wang, Liming Cao, Mingfeng Shan, Peng Wu, Ye Tian, Kai Zhou

Summary: This study investigated parents' attitudes towards vaccinating their children against COVID-19 in China and the influencing factors. The study found that children's age and recent physical condition were related to parents' willingness to vaccinate. Parents' major concerns were safety and unfamiliarity. Successful consultations with health workers increased parents' willingness to vaccinate.

INFECTION AND DRUG RESISTANCE (2022)

添加到收藏夹

Article Immunology

Incidence of Pharyngitis, Sinusitis, Acute Otitis Media, and Outpatient Antibiotic Prescribing Preventable by Vaccination Against Group A Streptococcus in the United States

Joseph A. Lewnard, Laura M. King, Katherine E. Fleming-Dutra, Ruth Link-Gelles, Chris A. Van Beneden

Summary: This study estimated healthcare visit rates and antibiotic prescription rates in the United States, and predicted the potential effects of vaccines targeting Group A Streptococcus under different dosing schedules. The results showed that the vaccine has the potential to prevent pharyngitis infections and related antibiotic use.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Preparing for Group B Streptococcus vaccine. Attitudes of pregnant women in two countries

Sarah Geoghegan, Jennifer Faerber, Laura Stephens, Hannah Gillan, Richard J. Drew, Maeve Eogan, Kristen A. Feemster, Karina M. Butler

Summary: Group B Streptococcus (GBS) vaccines are being tested in clinical trials for pregnant women. Preparatory research is needed to understand factors influencing GBS vaccine acceptance and to develop targeted interventions to improve uptake. A study in the US and Ireland found that awareness and understanding of GBS varied among participants, but overall, there was a high likelihood of vaccine receipt. Factors influencing acceptance included perceived infant benefit, while safety concerns were a barrier. Strong messaging emphasizing safety and potential benefits can help achieve good vaccine uptake.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

添加到收藏夹

Article Immunology

Attitudes towards vaccination and knowledge about antibiotics: Analysis of Wellcome Monitor survey data

Alistair Anderson

Summary: Vaccine hesitancy and attitudes towards antibiotic use are socially connected in the UK public, with negative vaccine perceptions associated with misunderstandings about antibiotic utility. This association can inform strategies for public health interventions targeting vaccine- and antibiotic-related issues.

VACCINE (2022)

添加到收藏夹

Article Microbiology

Hyaluronidase Impairs Neutrophil Function and Promotes Group B Streptococcus Invasion and Preterm Labor in Nonhuman Primates

Michelle Coleman, Blair Armistead, Austyn Orvis, Phoenicia Quach, Alyssa Brokaw, Claire Gendrin, Kavita Sharma, Jason Ogle, Sean Merillat, Matthew Dacanay, Tsung-Yen Wu, Jeff Munson, Audrey Baldessari, Jay Vornhagen, Anna Furuta, Shayla Nguyen, Kristina M. Adams Waldorf, Lakshmi Rajagopal

Summary: Invasive bacterial infections during pregnancy, such as Group B streptococci (GBS), can lead to preterm birth, stillbirth, and fetal injury. Using a nonhuman primate model, researchers found that GBS expressing hyaluronidase can cause microbial invasion into the amniotic cavity and preterm labor, shedding light on virulence factors and potential therapeutic strategies. Understanding how bacteria evade host defenses during pregnancy is crucial for developing preventive therapies against adverse outcomes.

MBIO (2021)

添加到收藏夹

Article Immunology

Secondary School Teachers and Outpatient Physicians: Differences in Attitudes towards Vaccination against COVID-19 in Slovakia

Maria Tatarkova, Romana Ulbrichtova, Viera Svihrova, Jana Zibolenova, Martin Novak, Jan Svihra, Henrieta Hudeckova

Summary: This study aimed to assess the differences in attitudes towards COVID-19 vaccination between secondary school teachers and outpatient physicians. The findings showed that outpatient physicians were more likely to be vaccinated against COVID-19, with the strongest motivation being the prevention of transmission in their professional setting. On the other hand, teachers expressed a greater concern for protecting their family members and showed more hesitancy towards vaccine safety.

VACCINES (2022)

添加到收藏夹

Article Immunology

Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis

Mirjam Freudenhammer, Konstantinos Karampatsas, Kirsty Le Doare, Fabian Lander, Jakob Armann, Daniel Acero Moreno, Margaret Boyle, Horst Buxmann, Ruth Campbell, Victoria Chalker, Robert Cunney, Lorraine Doherty, Eleri Davies, Androulla Efstratiou, Roland Elling, Matthias Endmann, Jochen Essers, Roland Hentschel, Christine E. Jones, Steffen Kallsen, Georgia Kapatai, Marcus Kruger, Shamez Ladhani, Theresa Lamagni, Diane Lindsay, Mary Meehan, Catherine P. O'Sullivan, Darshana Patel, Arlene J. Reynolds, Claudia Roll, Sven Schulzke, Andrew Smith, Anja Stein, Axel von der Wense, Egbert Voss, Christian Wieg, Christoph Hartel, Paul T. Heath, Philipp Henneke

Summary: The risk of iGBS is higher among infants from multiple births if one infant has already developed GBS disease. In recurrent cases, the interval of onset of iGBS between siblings is longer. Disturbances of the individual microbiome are suggested to be associated with recurrent GBS infections.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Attitudes and Behaviors towards Vaccination in Portuguese Nursing Students

Cristina Maria Alves Marques-Vieira, Tiago Dias Domingues, Adriana Dutra Tholl, Rosane Goncalves Nitschke, Francisco Javier Perez-Rivas, Maria Julia Ajejas-Bazan, Maria Clara Roquette-Viana

Summary: Knowing the attitudes and behaviors of nursing students towards vaccination is crucial for determining the health literacy of the population. This study aimed to analyze attitudes and behaviors of Portuguese nursing students regarding vaccination. Results showed that most students had positive attitudes and 84.7% had completed their COVID-19 vaccination. Being a nursing student, in the final years of the course, and female were the factors influencing positive attitudes. These results are encouraging as these students are likely to play a key role in health promotion programs through vaccination.

VACCINES (2023)

添加到收藏夹

Review Immunology

Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy

Alyssa Brokaw, Anna Furuta, Matthew Dacanay, Lakshmi Rajagopal, Kristina M. Adams Waldorf

Summary: Group B streptococcus colonization during pregnancy can lead to adverse outcomes, but there is currently no approved vaccine to prevent GBS infections. Understanding the pathogenesis of GBS disease may help in finding targeted therapeutic strategies to reduce the global burden of GBS infections.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

添加到收藏夹

Article Immunology

Perceptions and attitudes towards vaccination during pregnancy in a peri urban area of Lima, Peru

Andrea C. Carcelen, Alba Vilajeliu, Fauzia Malik, Robert H. Gilman, Saad Omer

Summary: Maternal immunization has the potential to reduce maternal and infant morbidity and mortality by protecting women from complications during pregnancy and providing protection for babies. Limited knowledge, concerns about vaccine safety during pregnancy, and lack of information were the main factors influencing pregnant women's vaccine uptake in Peru. Trust in healthcare providers and a desire for more information were highlighted as important for increasing vaccination uptake.

VACCINE (2021)

添加到收藏夹

Article Immunology

Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination

Helen R. Wagstaffe, Elizabeth A. Clutterbuck, Viki Bockstal, Jeroen N. Stoop, Kerstin Luhn, Macaya Douoguih, Georgi Shukarev, Matthew D. Snape, Andrew J. Pollard, Eleanor M. Riley, Martin R. Goodier

Summary: This study highlights the importance of antibody concentration and NK cell differentiation status in promoting Fc-mediated NK cell activation after Ebola virus vaccination, suggesting a potential role for antibody-mediated NK cell activation in vaccine-induced immune responses.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

S. A. Madhi, F. P. Polack, P. A. Piedra, F. M. Munoz, A. A. Trenholme, E. A. F. Simoes, G. K. Swamy, S. Agrawal, K. Ahmed, A. August, A. H. Baqui, A. Calvert, J. Chen, I. Cho, M. F. Cotton, C. L. Cutland, J. A. Englund, A. Fix, B. Gonik, L. Hammitt, P. T. Heath, J. N. de Jesus, C. E. Jones, A. Khalil, D. W. Kimberlin, R. Libster, C. J. Llapur, M. Lucero, G. Perez Marc, H. S. Marshall, M. S. Masenya, F. Martinon-Torres, J. K. Meece, T. M. Nolan, A. Osman, K. P. Perrett, J. S. Plested, P. C. Richmond, M. D. Snape, J. H. Shakib, V. Shinde, T. Stoney, D. N. Thomas, A. T. Tita, M. W. Varner, M. Vatish, K. Vrbicky, J. Wen, K. Zaman, H. J. Zar, G. M. Glenn, L. F. Fries

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Immunology

Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant series

Jennifer L. Oliver, Christine Sadorge, Florence Boisnard, Matthew D. Snape, Richard Tomlinson, Rebecca Mann, Peter Rudd, Shyam Bhakthavalsala, Saul N. Faust, Paul T. Heath, Stephen M. Hughes, Ray Borrow, Stephane Thomas, Adam Finn

VACCINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, Lily Y. Weckx, Pedro M. Folegatti, Parvinder K. Aley, Brian Angus, Vicky L. Baillie, Shaun L. Barnabas, Qasim E. Bhorat, Sagida Bibi, Carmen Briner, Paola Cicconi, Andrea M. Collins, Rachel Colin-Jones, Clare L. Cutland, Thomas C. Darton, Keertan Dheda, Christopher J. A. Duncan, Katherine R. W. Emary, Katie J. Ewer, Lee Fairlie, Saul N. Faust, Shuo Feng, Daniela M. Ferreira, Adam Finn, Anna L. Goodman, Catherine M. Green, Christopher A. Green, Paul T. Heath, Catherine Hill, Helen Hill, Ian Hirsch, Susanne H. C. Hodgson, Alane Izu, Susan Jackson, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Alison M. Lawrie, Alice Lelliott, Vincenzo Libri, Patrick J. Lillie, Raburn Mallory, Ana V. A. Mendes, Eveline P. Milan, Angela M. Minassian, Alastair McGregor, Hazel Morrison, Yama F. Mujadidi, Anusha Nana, Peter J. O'Reilly, Sherman D. Padayachee, Ana Pittella, Emma Plested, Katrina M. Pollock, Maheshi N. Ramasamy, Sarah Rhead, Alexandre V. Schwarzbold, Nisha Singh, Andrew Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca K. Sutherland, Richard Tarrant, Emma C. Thomson, M. Estee Torok, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya L. Villafana, Marion E. E. Watson, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

添加到收藏夹

Article Infectious Diseases

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results

Jenny M. MacLennan, Charlene M. C. Rodrigues, Holly B. Bratcher, Aiswarya Lekshmi, Adam Finn, Jenny Oliver, Mandy Wootton, Samantha Ray, Claire Cameron, Andrew Smith, Paul T. Heath, Angela Bartolf, Tracey Nolan, Stephen Hughes, Anu Varghese, Matthew D. Snape, Richard Sewell, Richard Cunningham, Alison Stolton, Carole Kay, Karen Palmer, David Baxter, Debbie Suggitt, Christos S. Zipitis, Nicola Pemberton, Keith A. Jolley, James E. Bray, Odile B. Harrison, Shamez N. Ladhani, Andrew J. Pollard, Raymond Borrow, Stephen J. Gray, Caroline Trotter, Martin C. J. Maiden

Summary: The incidence of invasive meningococcal disease in the UK decreased significantly from 1999 to 2014, particularly in serogroup C and serogroup B diseases. A survey conducted in 2014-15 showed a lower carriage prevalence of meningococci in adolescents compared to previous surveys, with a decline in behaviors associated with carriage.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial

Kimberly Davis, Marta Valente Pinto, Nick J. Andrews, David Goldblatt, Ray Borrow, Helen Findlow, Jo Southern, Jo Partington, Emma Plested, Sima Patel, Ann Holland, Mary Matheson, Anna England, Bassam Hallis, Elizabeth Miller, Matthew D. Snape

Summary: The study showed that the reduced-dose schedule of the multicomponent meningococcal vaccine 4CMenB in the UK has proven effective at preventing invasive group B meningococcal disease. Immunogenicity of the PCV13 and 4CMenB vaccines were assessed, with comparable results between the 2 + 1 and 1 + 1 schedules. Ongoing surveillance for vaccine breakthroughs is recommended due to potential suboptimal boost responses against certain meningococcal strains.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie J. Ewer, Jordan R. Barrett, Sandra Belij-Rammerstorfer, Hannah Sharpe, Rebecca Makinson, Richard Morter, Amy Flaxman, Daniel Wright, Duncan Bellamy, Mustapha Bittaye, Christina Dold, Nicholas M. Provine, Jeremy Aboagye, Jamie Fowler, Sarah E. Silk, Jennifer Alderson, Parvinder K. Aley, Brian Angus, Eleanor Berrie, Sagida Bibi, Paola Cicconi, Elizabeth A. Clutterbuck, Irina Chelysheva, Pedro M. Folegatti, Michelle Fuskova, Catherine M. Green, Daniel Jenkin, Simon Kerridge, Alison Lawrie, Angela M. Minassian, Maria Moore, Yama Mujadidi, Emma Plested, Ian Poulton, Maheshi N. Ramasamy, Hannah Robinson, Rinn Song, Matthew D. Snape, Richard Tarrant, Merryn Voysey, Marion E. E. Watson, Alexander D. Douglas, Adrian V. S. Hill, Sarah C. Gilbert, Andrew J. Pollard, Teresa Lambe

Summary: A single dose of the ChAdOx1 nCoV-19 vaccine can induce favorable immune responses that may help control or prevent SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, Sandra Belij-Rammerstorfer, Christina Dold, Katie J. Ewer, Pedro M. Folegatti, Ciaran Gilbride, Rachel Halkerston, Jennifer Hill, Daniel Jenkin, Lisa Stockdale, Marije K. Verheul, Parvinder K. Aley, Brian Angus, Duncan Bellamy, Eleanor Berrie, Sagida Bibi, Mustapha Bittaye, Miles W. Carroll, Breeze Cavell, Elizabeth A. Clutterbuck, Nick Edwards, Amy Flaxman, Michelle Fuskova, Andrew Gorringe, Bassam Hallis, Simon Kerridge, Alison M. Lawrie, Aline Linder, Xinxue Liu, Meera Madhavan, Rebecca Makinson, Jack Mellors, Angela Minassian, Maria Moore, Yama Mujadidi, Emma Plested, Ian Poulton, Maheshi N. Ramasamy, Hannah Robinson, Christine S. Rollier, Rinn Song, Matthew D. Snape, Richard Tarrant, Stephen Taylor, Kelly M. Thomas, Merryn Voysey, Marion E. E. Watson, Daniel Wright, Alexander D. Douglas, Catherine M. Green, Adrian V. S. Hill, Teresa Lambe, Sarah Gilbert, Andrew J. Pollard

Summary: The study demonstrates that a booster dose of ChAdOx1 nCoV-19 is safer and better tolerated than priming doses. The booster dose significantly enhances anti-spike neutralizing antibody titers and other functional antibody responses. These data support the two-dose vaccine regime currently being evaluated in phase 3 clinical trials.

NATURE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, Lily Y. Weckx, Pedro M. Folegatti, Parvinder K. Aley, Brian Angus, Vicky L. Baillie, Shaun L. Barnabas, Qasim E. Bhorat, Sagida Bibi, Carmen Briner, Paola Cicconi, Elizabeth A. Clutterbuck, Andrea M. Collins, Clare L. Cutland, Thomas C. Darton, Keertan Dheda, Christina Dold, Christopher J. A. Duncan, Katherine R. W. Emary, Katie J. Ewer, Amy Flaxman, Lee Fairlie, Saul N. Faust, Shuo Feng, Daniela M. Ferreira, Adam Finn, Eva Galiza, Anna L. Goodman, Catherine M. Green, Christopher A. Green, Melanie Greenland, Catherine Hill, Helen C. Hill, Ian Hirsch, Alane Izu, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Vincenzo Libri, Patrick J. Lillie, Natalie G. Marchevsky, Richard P. Marshall, Ana V. A. Mendes, Eveline P. Milan, Angela M. Minassian, Alastair McGregor, Yama F. Mujadidi, Anusha Nana, Sherman D. Padayachee, Daniel J. Phillips, Ana Pittella, Emma Plested, Katrina M. Pollock, Maheshi N. Ramasamy, Adam J. Ritchie, Hannah Robinson, Alexandre V. Schwarzbold, Andrew Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca K. Sutherland, Emma C. Thomson, M. Estee Torok, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya L. Villafana, Thomas White, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

添加到收藏夹

Letter Medicine, General & Internal

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data

Robert H. Shaw, Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S. Nguyen Van-Tam, Matthew D. Snape

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, Cristina Ariani, Brian Angus, Sagida Bibi, Beth Blane, David Bonsall, Paola Cicconi, Sue Charlton, Elizabeth A. Clutterbuck, Andrea M. Collins, Tony Cox, Thomas C. Darton, Christina Dold, Alexander D. Douglas, Christopher J. A. Duncan, Katie J. Ewer, Amy L. Flaxman, Saul N. Faust, Daniela M. Ferreira, Shuo Feng, Adam Finn, Pedro M. Folegatti, Michelle Fuskova, Eva Galiza, Anna L. Goodman, Catherine M. Green, Christopher A. Green, Melanie Greenland, Bassam Hallis, Paul T. Heath, Jodie Hay, Helen C. Hill, Daniel Jenkin, Simon Kerridge, Rajeka Lazarus, Vincenzo Libri, Patrick J. Lillie, Catherine Ludden, Natalie G. Marchevsky, Angela M. Minassian, Alastair C. McGregor, Yama F. Mujadidi, Daniel J. Phillips, Emma Plested, Katrina M. Pollock, Hannah Robinson, Andrew Smith, Rinn Song, Matthew D. Snape, Rebecca K. Sutherland, Emma C. Thomson, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya L. Villafana, Christopher J. Williams, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Merryn Voysey, Maheshi N. Ramasamy, Andrew J. Pollard

Summary: A post-hoc analysis was conducted on the efficacy of the ChAdOx1 nCoV-19 vaccine against the B.1.1.7 variant of SARS-CoV-2 in the UK. The vaccine showed reduced neutralisation activity against the B.1.1.7 variant in vitro, but still demonstrated efficacy against the B.1.1.7 variant of the virus.

LANCET (2021)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean-Daniel Lelievre, Christine Lacabaratz, Sophie Grande, Neil Goldstein, Cynthia Robinson, Auguste Gaddah, Viki Bockstal, Aurelie Wiedemann, Maarten Leyssen, Kerstin Luhn, Laura Richert, Christine Betard, Malick M. Gibani, Elizabeth A. Clutterbuck, Matthew D. Snape, Yves Levy, Macaya Douoguih, Rodolphe Thiebaut

Summary: The study evaluated the safety and immunogenicity of a two-dose heterologous vaccination regimen with Ad26.ZEBOV and MVA-BN-Filo against Ebola virus. The results showed that this regimen was safe, well tolerated, and induced long-lasting humoral and cellular immune responses.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

SARS-CoV-2 Variants and Vaccines

Philip R. Krause, Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba-Maria Ropero, Ran D. Balicer, Jakob P. Cramer, Cesar Munoz-Fontela, Marion Gruber, Rogerio Gaspar, Jerome A. Singh, Kanta Subbarao, Maria D. Van Kerkhove, Soumya Swaminathan, Michael J. Ryan, Ana-Maria Henao-Restrepo

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Multidisciplinary Sciences

Preventing type 1 diabetes in childhood

Colin M. Dayan, Rachel E. J. Besser, Richard A. Oram, William Hagopian, Manu Vatish, Owen Bendor-Samuel, Matthew D. Snape, John A. Todd

Summary: Recent studies have shown that monitoring pancreatic islet autoantibodies and genetic risk assessment can identify most children who will develop T1D, with immunotherapy and primary prevention methods showing success in delaying disease progression. By shifting focus towards early diagnosis and b cell preservation, a future without daily insulin injections for children with T1D is anticipated.

SCIENCE (2021)

添加到收藏夹

Article Pediatrics

Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019-2021

Helen Ratcliffe, K. S. Tiley, Nick Andrews, Gayatri Amirthalingam, I Vichos, E. Morey, N. L. Douglas, S. Marinou, Emma Plested, Parvinder Aley, Eva P. Galiza, Saul N. Faust, S. Hughes, Clare S. Murray, Marion Roderick, Fiona Shackley, Sam J. Oddie, Tim Lees, D. P. J. Turner, M. Raman, Stephen Owens, Paul Turner, H. Cockerill, J. Lopez Bernal, E. Linley, Ray Borrow, Kevin Brown, Mary Elizabeth Ramsay, M. Voysey, Matthew D. Snape

Summary: The objective of this study was to understand the community seroprevalence of SARS-CoV-2 in children and adolescents. The study found that approximately one-third of participants aged 15-18 years old had evidence of antibodies against SARS-CoV-2 prior to the introduction of widespread vaccination. Furthermore, ethnic background was found to be independently associated with the risk of SARS-CoV-2 infection in children.

ARCHIVES OF DISEASE IN CHILDHOOD (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.